CD4 and rheumatoid arthritis: The down-modulation of the PD-1 pathway is not because of inherent defective signaling in RA, since exogenous PD-L1-Fc was able to transduce its inhibitory signal in CD3-activated CD4+ T memory cells from RA patients, leading to decreased cell proliferation (Fig 3C).